Among TILs, the effector immune cells (CD8+T cells and Th1/CD4 + T cells) are associated with tumor immune elimination, while inhibitory phenotypes, such as CD4 + FoxP3 + T cells (Treg), are associated with tumor progression. This evidence concerns the gene CD8A and neoplasm.